000			02038 a2200601 4500
005			20250517034046.0
264		0	_c20160324
008			201603s 0 0 eng d
022			_a1873-281X
024	7		_a10.1016/j.tube.2015.04.011 _2doi
040			_aNLM _beng _cNLM
100	1		_aJayakumar, A
245	0	0	_aSerum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis. _h[electronic resource]
260			_bTuberculosis (Edinburgh, Scotland) _cJul 2015
300			_a415-20 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAge Factors
650	0	4	_aAntitubercular Agents _xtherapeutic use
650	0	4	_aBiomarkers _xblood
650	0	4	_aC-Reactive Protein _xmetabolism
650	0	4	_aCytokines _xblood
650	0	4	_aEnzyme-Linked Immunosorbent Assay
650	0	4	_aFemale
650	0	4	_aHost-Pathogen Interactions
650	0	4	_aHumans
650	0	4	_aLogistic Models
650	0	4	_aMale
650	0	4	_aMultivariate Analysis
650	0	4	_aMycobacterium tuberculosis _xdrug effects
650	0	4	_aPredictive Value of Tests
650	0	4	_aReceptors, Cytokine _xblood
650	0	4	_aReceptors, Tumor Necrosis Factor, Type I _xblood
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aTuberculosis, Pulmonary _xblood
650	0	4	_aUganda
650	0	4	_aYoung Adult
700	1		_aVittinghoff, E
700	1		_aSegal, M R
700	1		_aMacKenzie, W R
700	1		_aJohnson, J L
700	1		_aGitta, P
700	1		_aSaukkonen, J
700	1		_aAnderson, J
700	1		_aWeiner, M
700	1		_aEngle, M
700	1		_aYoon, C
700	1		_aKato-Maeda, M
700	1		_aNahid, P
773	0		_tTuberculosis (Edinburgh, Scotland) _gvol. 95 _gno. 4 _gp. 415-20
856	4	0	_uhttps://doi.org/10.1016/j.tube.2015.04.011 _zAvailable from publisher's website
999			_c24944660 _d24944660